Cargando…
Statin research in critical illness: hampered by poor trial design?
Statin therapy may prevent an excessive inflammatory response after cardiopulmonary bypass for cardiac surgery. In a recent issue of Critical Care, Morgan and colleagues present data from a well-conducted systematic review and meta-analysis of randomised controlled trials using inflammatory markers...
Autores principales: | Terblanche, Marius, Adhikari, Neill KJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811942/ https://www.ncbi.nlm.nih.gov/pubmed/20017899 http://dx.doi.org/10.1186/cc8173 |
Ejemplares similares
-
Statins, bugs and prophylaxis: intriguing possibilities
por: Terblanche, Marius, et al.
Publicado: (2006) -
Do statins have a role in preventing or treating sepsis?
por: Novack, Victor, et al.
Publicado: (2006) -
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study
por: Terblanche, Marius J, et al.
Publicado: (2011) -
Statins: a role in infected critically ill patients?
por: Truwit, Jonathon Dean
Publicado: (2011) -
The influence of statin exposure on inflammatory markers in patients with early bacterial infection: pilot prospective cohort study
por: Shankar-Hari, Manu, et al.
Publicado: (2014)